Evolution of the Average Target: Immatics N.V.

Evolution of the Target Price: Immatics N.V.

Changes in Analyst Recommendations: Immatics N.V.

0584ccbd8b9be4162846e38672414c22.H3W2uNcuJcUi7l03Wt9PSbSLJXVAV9MRUmwN91ltTyY.Rjfb6eZdTKRSlm1YEuooI9XsXDYjLaEkFj5AqA4fNUVUJ-nojmNWv0-FEA~d6239fcdde61d17b903808b56ede0ed0
04-28 TD Cowen Initiates Immatics at Buy MT
03-06 Deutsche Bank Lifts Price Target on Immatics to $18 From $17, Keeps Buy Rating MT
01-06 Biotech Sector Poised for Growth Driven by Trial Data, Pharma Deals, BofA Says MT
01-06 BofA Adjusts Price Target on Immatics to $17 From $14, Maintains Buy Rating MT
11-19 Mizuho Raises Price Target on Immatics to $23 From $19, Keeps Outperform Rating MT
25-09-18 Guggenheim Initiates Coverage on Immatics N.V With Buy Rating, $16 Price Target MT
25-05-28 Deutsche Bank Initiates Coverage on Immatics With Buy Rating, $10 Price Target MT
25-01-07 BofA Securities Adjusts Price Target on Immatics to $13 From $15, Maintains Buy Rating MT
24-10-07 Piper Sandler Initiates Immatics With Overweight Rating, $19 Price Target MT
24-05-15 Mizuho Raises Immatics' Price Target to $16 From $14, Keeps Buy Rating MT
23-11-02 Cantor Fitzgerald Initiates Coverage on Immatics with Overweight Rating MT
23-08-18 Mizuho Ups Price Target on Immatics to $14 From $12, Maintains Buy Rating MT
23-03-31 Mizuho Initiates Immatics at Buy With $12 Price Target MT
23-03-23 Chardan Adjusts Price Target on Immatics to $25 From $28, Keeps Buy Rating MT
22-08-10 Chardan Research Adjusts Price Target on Immatics to $28 From $30, Reiterates Buy Rating MT
22-06-03 SVB Securities Adjusts Immatics NV's Price Target to $26 from $25, Keeps Outperform Rating MT
22-03-24 SVB Leerink Adjusts Immatics' Price Target to $25 from $32, Keeps Outperform Rating MT
21-12-14 SVB Leerink Adjusts Immatics PT to $32 From $28, Maintains Outperform Rating MT
21-07-15 IMMATICS N : SVB Leerink Adjusts Immatics NV's Price Target to $27 from $26, Keeps Outperform Rating MT
21-03-18 IMMATICS N : Chardan Adjusts Immatics' Price Target to $30 From $28, Reiterates Buy Rating MT
21-03-17 IMMATICS N : SVB Leerink Adjusts Immatics NV Price Target to $26 From $17, Maintains Outperform Rating MT
20-11-20 IMMATICS N : BofA Securities Starts Immatics at Buy With $13 Price Target MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+91.97%
+9.72%
+42.1%
+36.27%
+105.79%
+51.99%
+41.35%
-5.61%
-23.54%
+31.71%
Average +38.17%
Weighted average by Cap. +33.05%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
9.780USD
Average target price
18.78USD
Spread / Average Target
+91.97%
High Price Target
25.00USD
Spread / Highest target
+155.62%
Low Price Target
12.20USD
Spread / Lowest Target
+24.74%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

TD Cowen
Deutsche Bank Securities
BofA Securities
Mizuho Securities
Guggenheim
Piper Sandler
Cantor Fitzgerald
Chardan Research
SVB Securities LLC
SVB Leerink
Chardan
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
9.780USD
Average target price
18.78USD
Spread / Average Target
+91.97%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IMTX Stock
  4. Consensus Immatics N.V.
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!